Ehmetdx, LLC

Ehmetdx, LLC specializes in developing software applications for CT systems. Their focus is on creating tools that enhance X-ray imaging capabilities, including general diagnostic imaging and specialized solutions like those integrated with proton therapy systems, such as the X-ray Imaging System for the McLaren Proton Treatment System. These applications are designed to improve imaging accuracy and workflow efficiency in clinical settings.

Ehmetdx, LLC is based in the United States. Since the company operates within the U.S., its devices must comply with U.S. medical device regulations, including those set by the FDA. The regulatory framework ensures that products like their CT system software meet safety, performance, and effectiveness standards before they are authorized for use.

Ehmetdx, LLC’s devices are listed in the FDA’s 510(k) and UDI (Unique Device Identifier) registries. The 510(k) process demonstrates that a device is substantially equivalent to a legally marketed predicate device, while the UDI system ensures accurate identification and traceability of medical devices throughout their lifecycle. Listing in these registries helps ensure transparency and compliance with U.S. regulatory requirements.

Ehmetdx, LLC’s devices fall under FDA’s Class II regulatory category. This classification indicates that while the devices pose moderate risk, they require special controls in addition to general controls to ensure their safety and effectiveness. Class II devices undergo a premarket notification (510(k)) process to demonstrate equivalence to existing authorized devices, ensuring they meet necessary regulatory standards before market authorization.